Conditions · Diabetes complications
Peripheral vascular disease
Peripheral vascular disease (PAD) is reduced blood flow to the limbs, most often the legs and feet, raising the risk of poor wound healing, pain with walking, and cardiovascular events. It's often silent — a large share of people with PAD have no symptoms, yet still carry meaningfully higher cardiovascular risk, which is why simple testing (an ABI) matters rather than waiting for leg pain. In India, PAD affects roughly 1 in 5 people with type 2 diabetes.
Your PAD assessment and management pathway
Clinical Exam
Checking pulses, skin changes, and your symptom history.
ABI Testing
A simple, non-invasive ankle-brachial index test — the primary way PAD is diagnosed.
Further Testing Where Needed
Toe-brachial index, Doppler studies, or imaging if the ABI result is inconclusive.
Classifying Your PAD
Determining whether it's asymptomatic, chronic symptomatic, or limb-threatening.
Building Your Treatment Plan
Risk factor control, medication, and exercise therapy matched to your classification.
Follow-Up and Vascular Referral
Ongoing review, with specialist vascular involvement where indicated.
Symptoms
- Leg pain or cramping with walking that eases with rest (claudication)
- Cold feet or legs, or a change in skin color
- Slow-healing wounds on the feet or legs
- Weak or absent pulses in the feet, on exam
Causes & risk factors
- Long-duration or poorly-controlled diabetes
- Smoking
- High blood pressure and abnormal cholesterol
- Age
Peripheral artery disease affects an estimated 18% of people with type 2 diabetes in India on average, with individual studies ranging from 2% to as high as 29.2%, and South Indian age-adjusted prevalence reported at up to 26.7%. Diabetes is the leading risk factor for PAD in India, ahead of cardiac disease, hypertension, and smoking.
The four types of PAD
PAD isn't a single presentation — current guidelines classify it into four clinical subsets, and which one applies to you shapes both urgency and treatment.
| Type | What it means | Typical presentation |
|---|---|---|
| Asymptomatic PAD | Reduced blood flow confirmed on testing, without noticeable symptoms | No symptoms reported, though some develop symptoms on a formal walking test |
| Chronic symptomatic PAD | Includes claudication — pain or cramping with walking | Leg or calf pain that comes on with activity and eases with rest |
| Chronic limb-threatening ischemia | Severely reduced blood flow threatening the limb | Pain at rest, non-healing wounds, or tissue loss |
| Acute limb ischemia | A sudden, severe drop in blood flow — a vascular emergency | Sudden severe pain, a pale or cold limb, or loss of pulse — needs immediate care |
Blood flow
PAD is reduced blood flow to the limbs, most often the legs and feet
Limb impact
Reduced flow slows healing and can cause pain, particularly with walking
Cardiovascular risk
PAD reflects blood vessel disease that also raises heart attack and stroke risk
Why silent PAD still matters
This is one of the more important, under-recognized points about PAD, and it mirrors what's also true of diabetic nerve and kidney complications — no symptoms doesn't mean no risk.
Asymptomatic doesn't mean risk-free
- Asymptomatic patients make up an estimated 20–59% of everyone with objectively confirmed PAD
- Many people who report no symptoms in daily life actually develop symptoms when given a formal walking test — the reduced blood flow was there, just not consciously noticed
- Asymptomatic PAD is still associated with meaningfully increased risk of major cardiovascular events, including heart attack and stroke — which is why testing, not just symptom-watching, is part of routine risk assessment
How PAD is diagnosed: the ABI test
The primary test is simple, quick, and non-invasive.
- The ankle-brachial index (ABI) compares blood pressure at your ankle to blood pressure at your arm — a lower ratio suggests reduced blood flow to the leg
- This is the first-line, guideline-recommended test for most patients with a history or exam findings suggestive of PAD
- If the resting ABI is inconclusive, further testing — toe-brachial index, Doppler studies, segmental pressures, or an exercise ABI — can clarify the picture
How PAD is treated
Treatment addresses both the underlying vessel disease and, where present, your specific symptoms.
| Approach | What it involves | Note |
|---|---|---|
| High-intensity statin therapy | A cholesterol-lowering medicine dosed to reduce LDL by 50% or more | See our dyslipidemia page for more on statin therapy generally |
| Antiplatelet therapy | A single antiplatelet medicine, such as aspirin or clopidogrel | Reduces cardiovascular event risk |
| Cilostazol | A medicine specifically for claudication symptoms | Improves walking distance for many patients; not used with any degree of heart failure |
| Supervised exercise therapy | A structured, supervised or guided walking program | A core, evidence-based treatment — genuinely more effective than general activity advice alone |
| Revascularization | A procedure to restore blood flow | Considered for limb-threatening disease or when other measures aren't sufficient |
PAD, diabetes, and foot health
PAD rarely acts alone in diabetes — it commonly occurs alongside diabetic peripheral neuropathy, and together the two are a major driver of foot ulcer risk: reduced sensation means an injury can go unnoticed, while reduced blood flow slows healing once it happens. See our diabetic peripheral neuropathy and diabetic foot ulcers pages for how these connect, and how foot risk is assessed and managed as a result.
How it’s diagnosed
Diagnosis starts with a clinical exam (pulses, skin changes) and is typically confirmed with a simple ankle-brachial index (ABI) test, with further non-invasive testing coordinated with partner facilities where specialist vascular imaging is needed.
How it’s treated
Management addresses the underlying risk factors (glucose, blood pressure, cholesterol, smoking cessation), high-intensity statin and antiplatelet therapy, symptom-specific medication where appropriate, supervised exercise therapy, and, in more advanced cases, referral for vascular intervention.
When to seek care
- New or worsening leg pain with walking
- A cold, painful, or discolored foot or leg
- A slow-healing wound on the foot or leg
- Sudden, severe leg pain with a pale, cold limb, or loss of pulse — a vascular emergency requiring immediate care
- Rest pain in the foot, especially at night
FAQ
Is peripheral vascular disease the same as peripheral neuropathy?
No — vascular disease affects blood flow, while neuropathy affects nerve sensation. They often occur together in diabetes and both contribute to foot ulcer risk.
What are the four types of PAD?
Asymptomatic PAD, chronic symptomatic PAD (including claudication), chronic limb-threatening ischemia, and acute limb ischemia — a sudden, severe vascular emergency.
What is claudication?
Leg or calf pain or cramping that comes on with walking and eases with rest — a classic symptom of chronic symptomatic PAD caused by reduced blood flow to the working muscle.
What is chronic limb-threatening ischemia?
A severe stage of PAD with pain at rest, non-healing wounds, or tissue loss, reflecting blood flow reduced enough to threaten the limb — it needs prompt, specialized evaluation.
What is acute limb ischemia, and why is it an emergency?
A sudden, severe drop in blood flow to a limb, causing sudden severe pain, a pale or cold limb, or loss of pulse — it threatens the limb within hours and needs immediate emergency care, not a routine appointment.
What is an ABI test?
The ankle-brachial index test compares blood pressure at your ankle to blood pressure at your arm. A lower ratio suggests reduced blood flow to the leg — it's simple, quick, and non-invasive.
Is PAD often silent, without symptoms?
Yes — asymptomatic patients make up an estimated 20–59% of everyone with confirmed PAD, and many who feel fine in daily life develop symptoms when given a formal walking test.
Does PAD still matter if I don't have symptoms?
Yes — asymptomatic PAD is still associated with meaningfully increased risk of major cardiovascular events, including heart attack and stroke, which is why testing is part of routine risk assessment rather than only symptom-driven care.
How is PAD treated?
With high-intensity statin therapy, antiplatelet medication, symptom-specific options like cilostazol for claudication, supervised exercise therapy, and, for more advanced disease, a procedure to restore blood flow.
What is cilostazol?
A medicine specifically for claudication symptoms that can improve walking distance for many patients — it isn't used in anyone with any degree of heart failure.
Do I need surgery for PAD?
Not usually — most patients are managed with medication, risk factor control, and exercise therapy. A procedure to restore blood flow is considered specifically for limb-threatening disease or when other measures aren't enough.
How does exercise therapy actually help?
Supervised or structured exercise programs are a core, evidence-based PAD treatment — genuinely more effective at improving walking distance and quality of life than general activity advice alone.
How common is PAD among people with diabetes in India?
Common — an estimated 18% of people with type 2 diabetes in India are affected on average, with some regional studies reporting rates as high as 26–29%.
Why does smoking matter so much for PAD?
Smoking is one of the strongest modifiable risk factors for PAD and accelerates blood vessel damage — smoking cessation is a core part of management alongside medication and exercise.
Sources
- 2024 ACC/AHA/Multisociety Guideline for the Management of Lower Extremity Peripheral Artery Disease
- Prevalence of peripheral arterial disease among individuals with type 2 diabetes mellitus in India: A systematic review and meta-analysis
- ADA Standards of Care 2026: Cardiovascular Disease and Risk Management
Medical disclaimer: Content on this page is for general education and is not a substitute for individualized medical advice, diagnosis, or treatment. Outcomes vary between patients. Boston Diabetes Center is outpatient / day-care specialty centre with an on-site diagnostic lab and pharmacy — no inpatient beds; imaging and inpatient care are coordinated through partner facilities.